Insider · CIK 0001269428
Matthew M Walsh
Files at OGN (Organon & Co.), CERT (Certara, Inc.). First filing May 6, 2025, latest May 6, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OGN: Organon & Co.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | Organon & Co. | $101k 11,400 shares | +9% | 0% from low-57% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | CERT Certara, Inc. | MOption exercise Common Stock | +11,928 | $0.00 | $0 | 197,559 | May 22, 2025 |
| May 21, 2025 | CERT Certara, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,928 | $0.00 | $0 | 0 | May 22, 2025 |
| May 21, 2025 | CERT Certara, Inc. | AGrant or award Restricted Stock Unitsderivative | +15,757 | $0.00 | $0 | 15,757 | May 22, 2025 |
| May 5, 2025 | OGN Organon & Co. | POpen-market purchase Common Stock | +11,400 | $8.82 | $101k | 144,484 | May 6, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +15,070 | $0.00 | $0 | 130,458 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -7,422 | $14.51 | $108k | 123,036 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +12,046 | $0.00 | $0 | 135,082 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -5,933 | $14.51 | $86k | 129,149 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +7,754 | $0.00 | $0 | 136,903 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -3,819 | $14.51 | $55k | 133,084 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Stock Option (right to buy)derivative | +317,656 | $0.00 | $0 | 317,656 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +64,640 | $0.00 | $0 | 64,640 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -15,070 | $0.00 | $0 | 30,142 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -12,046 | $0.00 | $0 | 12,047 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -7,754 | $0.00 | $0 | 0 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.